Smart insulin pump aims to take the guesswork out of diabetes management

NCT ID NCT05799781

Completed Disease control Sponsor: Oregon Health and Science University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new fully-closed insulin delivery system that automatically adjusts insulin based on activity and missed meals, compared to a standard hybrid system. 29 adults with type 1 diabetes used both systems to see which kept blood sugar in a healthy range more often. The goal is to make diabetes management easier and safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MPC closed-loop insulin delivery system (device)
What this could lead to: If successful, this could lead to a more automated insulin pump that better manages blood sugar without manual meal boluses, reducing the burden for people with type 1 diabetes.
What could go wrong: This is a small, early-stage study with only 29 participants, so results may not apply to everyone. The new algorithm may not outperform current systems and could have safety risks like low blood sugar.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Oregon Health and Science University

Portland, Oregon, 97239, United States
University of Washington

Seattle, Washington, 98105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.